University of Arizona, Tucson, 85721, USA.
Annu Rev Pharmacol Toxicol. 2010;50:111-29. doi: 10.1146/annurev.pharmtox.48.113006.094649.
c-MYC is an important regulator of a wide array of cellular processes necessary for normal cell growth and differentiation, and its dysregulation is one of the hallmarks of many cancers. Consequently, understanding c-MYC transcriptional activation is critical for understanding developmental and cancer biology, as well as for the development of new anticancer drugs. The nuclease hypersensitive element (NHE) III(1) region of the c-MYC promoter has been shown to be particularly important in regulating c-MYC expression. Specifically, the formation of a G-quadruplex structure appears to promote repression of c-MYC transcription. This review focuses on what is known about the formation of a G-quadruplex in the NHE III(1) region of the c-MYC promoter, as well as on those factors that are known to modulate its formation. Last, we discuss the development of small molecules that stabilize or induce the formation of G-quadruplex structures and could potentially be used as anticancer agents.
c-MYC 是一个广泛的细胞过程的重要调节者,这些过程对于正常细胞的生长和分化是必需的,其失调是许多癌症的标志之一。因此,理解 c-MYC 的转录激活对于理解发育和癌症生物学以及开发新的抗癌药物至关重要。已经表明,c-MYC 启动子的核酶敏感元件(NHE)III(1)区域在调节 c-MYC 表达方面特别重要。具体而言,形成 G-四链体结构似乎促进了 c-MYC 转录的抑制。本综述重点介绍了在 c-MYC 启动子的 NHE III(1)区域形成 G-四链体的已知情况,以及已知调节其形成的因素。最后,我们讨论了开发能够稳定或诱导 G-四链体结构形成的小分子的可能性,并可能将其用作抗癌剂。